Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X NASDAQ 100 Covered Call ETF vs Tilray Brands Inc — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $18.35, while Tilray Brands Inc trades at $4.21 (market cap $577.15M). The key difference: Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| QYLD | TLRY | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $18.52 | $21.00 |
52-Week Low | $16.70 | $3.88 |
Market Cap | — | $577.15M |
Enterprise Value | — | $744.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QYLD trades at $18.37, up 0.05% with a bullish technical signal from moving averages. The ETF generates income through covered calls on the NASDAQ-100, providing an estimated 11-12% yield but limiting upside participation in strong bull markets. Recent dividend payments of $0.18-$0.19 per share demonstrate consistent income generation while the underlying index experiences volatility.
The outlook remains mixed - QYLD offers attractive monthly income for retirees but has historically underperformed the NASDAQ-100 during sustained rallies. Principal erosion risk exists as the strategy caps gains during market advances. Investors should weigh high yield against potential long-term capital appreciation sacrifice in tech-heavy markets.
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
